资讯
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...
Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are ...
Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.
Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and ...
1 天on MSN
Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get ...
Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.
GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...
This retrospective cohort study found that taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) was associated with a reduced overall risk of cancer, including lower risks of endometrial, ...
4 天
HealthDay on MSN26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
In 2024, 26.5% of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables.
8 天
ScienceAlert on MSNSomething Inside Your Gut Could Be Like a Natural Ozempic
Ozempic and drugs like it have done wonders for weight loss by mimicking the natural hormone GLP-1 ( glucagon-like peptide-1 ...
By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果